Back

prof. dr. J.H.H.M. (Janneke) van de Wijgert

Full Professor

  • Department of Epidemiology
  • Julius Center Research Program Infectious Diseases

prof. dr. J.H.H.M. (Janneke) van de Wijgert

Research Programs

Biography

Prof. Janneke van de Wijgert, MD PhD MPH, is a translational infectious disease researcher, educated in biomedical sciences and medicine (Utrecht University, Netherlands), and public health epidemiology (University of California at Berkeley, USA). Her work experience includes clinical epidemiological and public health research, laboratory research, and product development in various European, African, Asian, and American countries. Former employers include the University of California at San Franciscio (5 years of which as Director of the UZ-UCSF Collaborative HIV Research Program in Harare, Zimbabwe), the Population Council in New York, and the Amsterdam Institute for Global Health and Development at the Amsterdam University Medical Center. She was appointed Full Professor in the Institute of Infection and Global Health at the University of Liverpool in 2012 and in the Julius Center for Health Sciences and Primary Care of the University Medical Center Utrecht in 2017. She currently still divides her time between Utrecht and Liverpool. She has supervised/is supervising multiple PhD, Master’s and Bachelor students, and has published more than 160 peer-reviewed papers.
 
Janneke van de Wijgert’s main areas of research and teaching include 1) general infectious and immune-mediated disease epidemiology (including COVID-19); 2) the role of the human microbiome in health and disease; 3) the role of the cervicovaginal microbiome in reproductive and neonatal health and disease, and in prevention of HIV transmission; and 4) evaluation of diagnostics, treatments, and prevention interventions in these areas. In addition to traditional epidemiological approaches, she has specialised in incorporating ‘-omics’ and other complex biological data into epidemiological models. During the COVID-19 epidemic, she has worked with eHealth applications to control epidemic spread.

 

 

Side Activities

  • Lid van de Begeleidingscommissie Digitale Ondersteuning Bestrijding Covid-19 van het Ministerie van VWS;

    Regular peer reviewer for journals and funding agencies;

    Regular invited speaker, session chair, or Scientific Advisory Committee member at scientific meetings and conferences.

    Advisor of biotech companies in infectious disease diagnostics and therapeutics (unpaid).

     

Research Output (65)

Thoracic imaging tests for the diagnosis of COVID-19

Islam Nayaar, Salameh Jean-Paul, Leeflang Mariska Mg, Hooft Lotty, McGrath Trevor A, van der Pol Christian B, Frank Robert A, Kazi Sakib, Prager Ross, Hare Samanjit S, Dennie Carole, Spijker René, Deeks Jonathan J, Dinnes Jacqueline, Jenniskens Kevin, Korevaar Daniël A, Cohen Jérémie F, Van den Bruel Ann, Takwoingi Yemisi, van de Wijgert Janneke, Wang Junfeng, McInnes Matthew Df, 26 nov 2020, In: The Cochrane database of systematic reviews. 2020 , p. CD013639

Impact of delays on effectiveness of contact tracing strategies for COVID-19:a modelling study

Kretzschmar Mirjam E, Rozhnova Ganna, Bootsma Martin C J, van Boven Michiel, van de Wijgert Janneke H H M, Bonten Marc J M 16 jul 2020, In: The Lancet Public Health. 5 , p. e452-e459

Erratum:Correction to: Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials (Trials (2020) 21 1 (481))

Ten Doesschate Thijs, Moorlag Simone J C F M, van der Vaart Thomas W, Taks Esther, Debisarun Priya, Ten Oever Jaap, Bleeker-Rovers Chantal P, Verhagen Patricia Bruijning, Lalmohamed Arief, Ter Heine Rob, van Crevel Reinout, van de Wijgert Janneke, Janssen Axel B, Bonten Marc J, van Werkhoven Cornelis H, Netea Mihai G, 22 jun 2020, In: Trials. 21 , p. 555 1 p.

Two Randomized Controlled Trials of Bacillus Calmette-Guerin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials:A structured summary of the study protocols for two randomised controlled trials

Ten Doesschate Thijs, Moorlag Simone J C F M, van der Vaart Thomas W, Taks Esther, Debisarun Priya, Ten Oever Jaap, Bleeker-Rovers Chantal P, Verhagen Patricia Bruijning, Lalmohamed Arief, Ter Heine Rob, van Crevel Reinout, van de Wijgert Janneke, Janssen Axel B, Bonten Marc J, van Werkhoven Cornelis H, Netea Mihai G, 5 jun 2020, In: Trials. 21 2 p.

Vaginal probiotic adherence and acceptability in Rwandan women with high sexual risk participating in a pilot randomised controlled trial:a mixed-methods approach

Verwijs Marijn C, Agaba Stephen, Umulisa Marie Michele, Uwineza Mireille, Nivoliez Adrien, Lievens Elke, van de Wijgert Janneke H H M 19 mei 2020, In: BMJ Open. 10 , p. e031819

Health-related quality of life in patients with immune mediated inflammatory diseases:A cross-sectional, multidisciplinary study

Spierings Julia, Sloeserwij Annemiek, Vianen Marieke E., de Boer Joke H., Sigurdsson Vigfus, van de Wijgert Janneke H.H.M., van Laar Jacob M. 26 mrt 2020, In: Clinical Immunology. 214

ECHO:context and limitations

Jewell Britta L, Smith Jennifer A, Padian Nancy S, van de Wijgert Janneke H H M, Gollub Erica L, Jones Heidi E, Ralph Lauren J, Hallett Timothy B 8 feb 2020, In: The Lancet. 395 , p. e25-e26

ECHO:context and limitations

Gollub Erica L, Stein Zena, van de Wijgert Janneke H H M, Jones Heidi, Ralph Lauren, Padian Nancy 8 feb 2020, In: The Lancet. 395 , p. e24

Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis:a systematic review and recommendations for future trial designs

van de Wijgert Jhhm, Verwijs M C 1 jan 2020, In: BJOG - An International Journal of Obstetrics and Gynaecology. 127 , p. 287-299 13 p.

Authors' reply re:Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs

van de Wijgert Janneke Hhm, Verwijs Marijn C 1 jan 2020, In: BJOG - An International Journal of Obstetrics and Gynaecology. 127 , p. 305 1 p.

All Research Output (65)